Julian Halcox
Julian Halcox
Professor of Cardiology, Swansea University UK
Verified email at
Cited by
Cited by
2016 ESC/EAS guidelines for the management of dyslipidaemias
AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ...
Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
JM Hill, G Zalos, JPJ Halcox, WH Schenke, MA Waclawiw, AA Quyyumi, ...
New England Journal of Medicine 348 (7), 593-600, 2003
Endothelial function and dysfunction: testing and clinical relevance
JE Deanfield, JP Halcox, TJ Rabelink
Circulation 115 (10), 1285-1295, 2007
Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio …
Developed with the Special Contribution of the European Association for ...
European heart journal 31 (20), 2501-2555, 2010
Prognostic value of coronary vascular endothelial dysfunction
JPJ Halcox, WH Schenke, G Zalos, R Mincemoyer, A Prasad, ...
Circulation 106 (6), 653-658, 2002
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial …
H Brunner, JR Cockcroft, J Deanfield, A Donald, E Ferrannini, J Halcox, ...
Journal of hypertension 23 (2), 233-246, 2005
Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration
B Freedman, J Camm, H Calkins, JS Healey, M Rosenqvist, J Wang, ...
Circulation 135 (19), 1851-1867, 2017
Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study
JPJ Halcox, K Wareham, A Cardew, M Gilmore, JP Barry, C Phillips, ...
Circulation 136 (19), 1784-1794, 2017
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
JR Banegas, E López-García, J Dallongeville, E Guallar, JP Halcox, ...
European heart journal 32 (17), 2143-2152, 2011
Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation …
EACPR Committee for Science Guidelines, U Corrà, MF Piepoli, F Carré, ...
European heart journal 31 (16), 1967-1974, 2010
ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of …
European Association for Cardiovascular Prevention & Rehabilitation, ...
Eur Heart J 32 (14), 1769-818, 2011
Predisposition to atherosclerosis by infections: role of endothelial dysfunction
A Prasad, J Zhu, JPJ Halcox, MA Waclawiw, SE Epstein, AA Quyyumi
Circulation 106 (2), 184-190, 2002
Endothelial function predicts progression of carotid intima-media thickness
JPJ Halcox, AE Donald, E Ellins, DR Witte, MJ Shipley, EJ Brunner, ...
Circulation 119 (7), 1005-1012, 2009
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non …
CA Bannister, SE Holden, S Jenkins‐Jones, CL Morgan, JP Halcox, ...
Diabetes, Obesity and Metabolism 16 (11), 1165-1173, 2014
The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia
JPJ Halcox, KRA Nour, G Zalos, R Mincemoyer, MA Waclawiw, CE Rivera, ...
Journal of the American College of Cardiology 40 (7), 1232-1240, 2002
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
DH McDermott, JPJ Halcox, WH Schenke, MA Waclawiw, MN Merrell, ...
Circulation research 89 (5), 401-407, 2001
Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis
J Zhu, AA Quyyumi, D Rott, G Csako, H Wu, J Halcox, SE Epstein
Circulation 103 (8), 1071-1075, 2001
Beyond the laboratory: clinical implications for statin pleiotropy
JPJ Halcox, JE Deanfield
Circulation 109 (21_suppl_1), II-42-II-48, 2004
Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation
AE Donald, JP Halcox, M Charakida, C Storry, SML Wallace, TJ Cole, ...
Journal of the American College of Cardiology 51 (20), 1959-1964, 2008
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
The system can't perform the operation now. Try again later.
Articles 1–20